BioSpace News Archive

Edmund Optics®, a leading global manufacturer and supplier of optical components, has been officially ISO 13485 certified.

Maruho Medical, Inc., a medical device manufacturer providing innovative solutions for orthopedic sports medicine surgery and soft tissue repair, has named Bret Schwartzhoff Senior Vice President of Sales & Marketing.

Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for additional claims that cover its oral testosterone replacement product, JATENZO (testosterone undecanoate).

Daewoong Pharmaceutical Co., Ltd. presented its management performance for the second quarter of 2022.

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) (“NeuroSense”), and NeuraLight, a company developing objective and sensitive biomarkers for neurological disorders, today announced a collaboration to advance the science of digital biomarkers in the detection and monitoring of neurological diseases including amyotrophic lateral sclerosis (ALS).

Seagen Inc. reported financial results for the second quarter ended June 30, 2022.

Matinas BioPharma Holdings, Inc. announced the Company will host a conference call and live audio webcast on Thursday, August 11, 2022 at 8:30 a.m. ET to discuss operational and financial results for the second quarter ended June 30, 2022.

VolitionRx Limited, a multi-national epigenetics company, announced that it has commenced an underwritten public offering of its common stock.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its second quarter 2022 financial results after the market closes on Thursday, August 4, 2022.

MorphoSys AG ; will publish its results for the second quarter and first half year 2022 results on August 3, 2022 at 10:00 pm CEST.